Literature DB >> 15145637

Cerebral palsy.

L Andrew Koman1, Beth Paterson Smith, Jeffrey S Shilt.   

Abstract

Cerebral palsy, a range of non-progressive syndromes of posture and motor impairment, is a common cause of disability in childhood. The disorder results from various insults to different areas within the developing nervous system, which partly explains the variability of clinical findings. Management options include physiotherapy, occupational and speech therapy, orthotics, device-assisted modalities, pharmacological intervention, and orthopaedic and neurosurgical procedures. Since 1980, modification of spasticity by means of orally administered drugs, intramuscular chemodenervation agents (alcohol, phenol, botulinum toxin A), intrathecally administered drugs (baclofen), and surgery (neurectomy, rhizotomy) has become more frequent. Family-directed use of holistic approaches for their children with cerebral palsy includes the widespread adoption of complementary and alternative therapies; however, the prevalence of their use and the cost of these options are unknown. Traditional medical techniques (physiotherapy, bracing, and orthopaedic musculoskeletal surgery) remain the mainstay of treatment strategies at this time. This seminar addresses only the musculoskeletal issues associated with cerebral palsy and only indirectly discusses the cognitive, medical, and social issues associated with this diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 15145637     DOI: 10.1016/S0140-6736(04)16207-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  89 in total

Review 1.  Therapeutic interventions in cerebral palsy.

Authors:  Dilip R Patel
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

2.  Tibialis anterior architecture, strength, and gait in individuals with cerebral palsy.

Authors:  Daniel C Bland; Laura A Prosser; Lindsey A Bellini; Katharine E Alter; Diane L Damiano
Journal:  Muscle Nerve       Date:  2011-07-13       Impact factor: 3.217

3.  Editorial on "The management of childhood hypertonia".

Authors:  Rick Abbott
Journal:  Childs Nerv Syst       Date:  2007-06-14       Impact factor: 1.475

4.  Higher expression of myosin heavy chain IIx in wrist flexors in cerebral palsy.

Authors:  Stefan Gantelius; Yvette Hedström; Eva Pontén
Journal:  Clin Orthop Relat Res       Date:  2012-05       Impact factor: 4.176

5.  Adductor tenotomy and selective obturator neurectomy for the treatment of spasticity in a man with paraplegia.

Authors:  Ahmad Zaheer Qureshi; Subramanya Adiga
Journal:  J Spinal Cord Med       Date:  2013-01       Impact factor: 1.985

6.  Unmyelinated axon loss with postnatal hypertonia after fetal hypoxia.

Authors:  Alexander Drobyshevsky; Rugang Jiang; Laixiang Lin; Matthew Derrick; Kehuan Luo; Stephen A Back; Sidhartha Tan
Journal:  Ann Neurol       Date:  2014-03-13       Impact factor: 10.422

7.  The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.

Authors:  Lee Barber; Tandy Hastings-Ison; Richard Baker; H Kerr Graham; Rod Barrett; Glen Lichtwark
Journal:  J Child Orthop       Date:  2013-06-18       Impact factor: 1.548

8.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

Review 9.  Single-level selective dorsal rhizotomy for spastic cerebral palsy.

Authors:  David Graham; Kristian Aquilina; Stephanie Cawker; Simon Paget; Neil Wimalasundera
Journal:  J Spine Surg       Date:  2016-09

10.  Novel transcriptional profile in wrist muscles from cerebral palsy patients.

Authors:  Lucas R Smith; Eva Pontén; Yvette Hedström; Samuel R Ward; Henry G Chambers; Shankar Subramaniam; Richard L Lieber
Journal:  BMC Med Genomics       Date:  2009-07-14       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.